A-Life Medical selected as Finalist for Crimson Herrings North America 100 award A-Life Medical.

We know that this year’s crop will develop into some amazing companies that will definitely go considerably. Finalists for the 2010 edition of the Red Herring 100 North America award are selected based upon their know-how, management strength, market size, investor record, consumer acquisition, and financial health. Through the several months before the announcement, hundreds of companies in the telecommunications, security, Blogging platforms 2.0, software, hardware, biotech, and clean tech industries submitted their submissions to be eligible for the award. The Finalists are invited to present their winning strategies at the Red Herring THE UNITED STATES Conference in NORTH PARK, June 22-24, 2010.Retain POC urine medication screening as a crucial diagnostic tool for doctors. Help protect individuals and the public from the harmful consequences of prescription substance abuse. Current Situation of Concern Presently, a proposal is usually before CMS to significantly trim reimbursement for point-of-care test devices used in urine medication screening. Outside interests are proposing these drastic cuts to CMS based on the premise that physicians should not bill CMS for multiple drug checks when doing in-workplace urine analysis.